Clearmind Medicine Inc. Common Shares (CMND) — Strategic Asset Allocation Index
Clearmind Medicine Inc. Common Shares (CMND) has a Strategic Asset Allocation Index of 0.3% as of July 2023. Strategic assets (PP&E of $7.30K plus long-term investments of $-) total $7.30K, measured against net assets of $2.13 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See CMND net asset quality index to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Clearmind Medicine Inc. Common Shares Strategic Asset Allocation Index (2018–2021)
This chart shows how Clearmind Medicine Inc. Common Shares's Strategic Asset Allocation Index has evolved across 3 annual periods from 2018 to 2021. As of July 2023, the index stands at 0.3%, representing strategic assets of $7.30K against net assets of $2.13 Million USD. For live market cap and overall valuation, see CMND market cap.
Annual Strategic Asset Allocation Index for Clearmind Medicine Inc. Common Shares (2018–2021)
The table below presents the year-by-year Strategic Asset Allocation Index for Clearmind Medicine Inc. Common Shares from 2018 to 2021, covering 3 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See Clearmind Medicine Inc. Common Shares book value and equity for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 0.5% | $20.58K | $20.58K | $- | $3.87 Million | ▼ -171.3 pp |
| 2019 | 171.8% | $174.59K | $174.59K | $- | $101.63K | ▲ +81.5 pp |
| 2018 | 90.3% | $164.59K | $164.59K | $- | $182.24K | — |